These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24159176)

  • 1. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome.
    Nocturne G; Boudaoud S; Miceli-Richard C; Viengchareun S; Lazure T; Nititham J; Taylor KE; Ma A; Busato F; Melki J; Lessard CJ; Sivils KL; Dubost JJ; Hachulla E; Gottenberg JE; Lombès M; Tost J; Criswell LA; Mariette X
    Blood; 2013 Dec; 122(25):4068-76. PubMed ID: 24159176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline variation of TNFAIP3 in primary Sjögren's syndrome-associated lymphoma.
    Nocturne G; Tarn J; Boudaoud S; Locke J; Miceli-Richard C; Hachulla E; Dubost JJ; Bowman S; Gottenberg JE; Criswell LA; Lessard CJ; Sivils KL; Carapito R; Bahram S; Seror R; Ng WF; Mariette X
    Ann Rheum Dis; 2016 Apr; 75(4):780-3. PubMed ID: 26338037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Protein A20 in Minor Salivary Glands is Associated with Lymphoma in Primary Sjögren's Syndrome.
    Johnsen SJ; Gudlaugsson E; Skaland I; Janssen EA; Jonsson MV; Helgeland L; Berget E; Jonsson R; Omdal R
    Scand J Immunol; 2016 Mar; 83(3):181-7. PubMed ID: 26679293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association studies of TNFSF4, TNFAIP3 and FAM167A-BLK polymorphisms with primary Sjogren's syndrome in Han Chinese.
    Sun F; Li P; Chen H; Wu Z; Xu J; Shen M; Leng X; Shi Q; Zhang W; Tian X; Li Y; Zhang F
    J Hum Genet; 2013 Jul; 58(7):475-9. PubMed ID: 23635951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients.
    Nezos A; Gkioka E; Koutsilieris M; Voulgarelis M; Tzioufas AG; Mavragani CP
    J Immunol Res; 2018; 2018():6923213. PubMed ID: 30662920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A failure of TNFAIP3 negative regulation maintains sustained NF-κB activation in Sjögren's syndrome.
    Sisto M; Lisi S; Lofrumento DD; Ingravallo G; Maiorano E; D'Amore M
    Histochem Cell Biol; 2011 Jun; 135(6):615-25. PubMed ID: 21604024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFAIP3 Gene Polymorphisms in Three Common Autoimmune Diseases: Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Primary Sjogren Syndrome-Association with Disease Susceptibility and Clinical Phenotypes in Italian Patients.
    Ciccacci C; Latini A; Perricone C; Conigliaro P; Colafrancesco S; Ceccarelli F; Priori R; Conti F; Perricone R; Novelli G; Borgiani P
    J Immunol Res; 2019; 2019():6728694. PubMed ID: 31534975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
    Sisto M; Barca A; Lofrumento DD; Lisi S
    Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome.
    Nordmark G; Wang C; Vasaitis L; Eriksson P; Theander E; Kvarnström M; Forsblad-d'Elia H; Jazebi H; Sjöwall C; Reksten TR; Brun JG; Jonsson MV; Johnsen SJ; Wahren-Herlenius M; Omdal R; Jonsson R; Bowman S; Ng WF; Eloranta ML; Syvänen AC;
    Scand J Immunol; 2013 Nov; 78(5):447-54. PubMed ID: 23944604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An enhancer element harboring variants associated with systemic lupus erythematosus engages the TNFAIP3 promoter to influence A20 expression.
    Wang S; Wen F; Wiley GB; Kinter MT; Gaffney PM
    PLoS Genet; 2013; 9(9):e1003750. PubMed ID: 24039598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A20 inactivation in ocular adnexal MALT lymphoma.
    Bi Y; Zeng N; Chanudet E; Huang Y; Hamoudi RA; Liu H; Dong G; Watkins AJ; Ley SC; Zou L; Chen R; Zhu X; Du MQ
    Haematologica; 2012 Jun; 97(6):926-30. PubMed ID: 22207688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
    Novak U; Rinaldi A; Kwee I; Nandula SV; Rancoita PM; Compagno M; Cerri M; Rossi D; Murty VV; Zucca E; Gaidano G; Dalla-Favera R; Pasqualucci L; Bhagat G; Bertoni F
    Blood; 2009 May; 113(20):4918-21. PubMed ID: 19258598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
    Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
    J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FcRL4
    Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
    J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.
    Schmitz R; Hansmann ML; Bohle V; Martin-Subero JI; Hartmann S; Mechtersheimer G; Klapper W; Vater I; Giefing M; Gesk S; Stanelle J; Siebert R; Küppers R
    J Exp Med; 2009 May; 206(5):981-9. PubMed ID: 19380639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.
    Ando M; Sato Y; Takata K; Nomoto J; Nakamura S; Ohshima K; Takeuchi T; Orita Y; Kobayashi Y; Yoshino T
    PLoS One; 2013; 8(2):e56741. PubMed ID: 23418597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of NF-κB signal pathway-related genes in ocular MALT lymphoma.
    Liu F; Karube K; Kato H; Arita K; Yoshida N; Yamamoto K; Tsuzuki S; Kim W; Ko YH; Seto M
    Int J Clin Exp Pathol; 2012; 5(5):436-41. PubMed ID: 22808296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation.
    Papageorgiou A; Mavragani CP; Nezos A; Zintzaras E; Quartuccio L; De Vita S; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
    Arthritis Rheumatol; 2015 Oct; 67(10):2732-41. PubMed ID: 26097183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23.
    Li Y; Zhang K; Chen H; Sun F; Xu J; Wu Z; Li P; Zhang L; Du Y; Luan H; Li X; Wu L; Li H; Wu H; Li X; Li X; Zhang X; Gong L; Dai L; Sun L; Zuo X; Xu J; Gong H; Li Z; Tong S; Wu M; Li X; Xiao W; Wang G; Zhu P; Shen M; Liu S; Zhao D; Liu W; Wang Y; Huang C; Jiang Q; Liu G; Liu B; Hu S; Zhang W; Zhang Z; You X; Li M; Hao W; Zhao C; Leng X; Bi L; Wang Y; Zhang F; Shi Q; Qi W; Zhang X; Jia Y; Su J; Li Q; Hou Y; Wu Q; Xu D; Zheng W; Zhang M; Wang Q; Fei Y; Zhang X; Li J; Jiang Y; Tian X; Zhao L; Wang L; Zhou B; Li Y; Zhao Y; Zeng X; Ott J; Wang J; Zhang F
    Nat Genet; 2013 Nov; 45(11):1361-5. PubMed ID: 24097066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent inactivation of A20 in B-cell lymphomas.
    Kato M; Sanada M; Kato I; Sato Y; Takita J; Takeuchi K; Niwa A; Chen Y; Nakazaki K; Nomoto J; Asakura Y; Muto S; Tamura A; Iio M; Akatsuka Y; Hayashi Y; Mori H; Igarashi T; Kurokawa M; Chiba S; Mori S; Ishikawa Y; Okamoto K; Tobinai K; Nakagama H; Nakahata T; Yoshino T; Kobayashi Y; Ogawa S
    Nature; 2009 Jun; 459(7247):712-6. PubMed ID: 19412163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.